HEAT BIOLOGICS, INC. | Business Contracts

Amendment No. 1 to William Ostrander Employment Agreement with the Company dated as of December 7, 2022 (Filed With SEC on December 9, 2022)

Patent License Agreement between the Board of Regents of the University of Texas System and Elusys Therapeutics, Inc (Filed With SEC on April 20, 2022)

Amendment No. 4 to the Rights Agreement dated as of March 8, 2021 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 11, 2022)

CPRIT Grant (Filed With SEC on March 11, 2022)

Merger Agreement, dated December 20, 2021, by and among Heat Biologics, Inc., Heat Acquisition Sub 1, Inc. and Elusys Therapeutics, Inc (Filed With SEC on December 21, 2021)

Lease between Merchants Ice II, LLC and Heat Biologics, Inc. dated October 5, 2021 (Filed With SEC on October 7, 2021)

Amended and Restated Sales Agreement, dated August 24, 2020, among Heat Biologics, Inc., B. Riley Securities, Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 24, 2020)

Amendment No. 1 to Jeff Wolf Employment Agreement with the Company dated as of December 7, 2022 (Filed With SEC on December 9, 2022)

Assignment and Assumption Agreement between Heat Biologics, Inc. and Pelican Therapeutics, Inc.(f/k/a Heat Biologics II, Inc.) dated June 26, 2009 (UM131-31, UM139) (Filed With SEC on March 11, 2022)

License Agreement by and between University of Miami and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated November 19, 2013 (UMI143 and UMN 106) (Filed With SEC on March 11, 2022)

Second Amendment to License Agreement between Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) and University of Miami dated August 11, 2009 (UMC-131, UMC-139)... (Filed With SEC on March 11, 2022)

Amendment to License Agreement between Heat Biologics, Inc. and University of Miami (UM03-31, UM05-39) dated April 20, 2009 (Filed With SEC on March 11, 2022)

License Agreement by and between University of Miami and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.) dated December 12, 2010 (UMI176) (Filed With SEC on March 11, 2022)

License Agreement by and between University of Miami and Pelican Therapeutics, Inc. (f/k/a Heat Biologics II, Inc.), dated July 11, 2008, (UM03-31, UM05-39) (Filed With SEC on March 11, 2022)

Description of Securities of Heat Biologics, Inc (Filed With SEC on March 11, 2022)

Form of New Incentive Option Agreement for awards subject to forfeiture (Filed With SEC on January 3, 2022)

Form of New Non-Statutory Stock Option Agreement for awards subject to forfeiture (Filed With SEC on January 3, 2022)

Employment Agreement between Heat Biologics, Inc. and William Ostrander, dated as of December 13, 2021 (Filed With SEC on December 15, 2021)

Form of Amended and Restated Restricted Stock Agreement (Filed With SEC on December 15, 2021)

License Agreement between University of Miami and Zolovax, Inc. dated October 24, 2016 (Filed With SEC on August 11, 2021)

License Agreement (UMSS114A) between University of Miami and Heat Biologics 1, Inc. dated February 18, 2011 (Filed With SEC on August 11, 2021)

License Agreement (UMD-107)between University of Miami and Heat Biologics 1, Inc. dated February 18, 2011 (Filed With SEC on August 11, 2021)

License Agreement (UM-97-14) between University of Miami and Heat Biologics, Inc. dated July 11, 2008 (Filed With SEC on August 11, 2021)

Form of Restricted Stock Purchase Agreement for the Heat Biologics 2021 Subsidiaries Stock Incentive Plan (Filed With SEC on August 3, 2021)

Form of Stock Option Agreement for the Heat Biologics 2021 Subsidiaries Stock Incentive Plan (Filed With SEC on August 3, 2021)

Lease between Durham Keystone Tech 7, LLC and Heat Biologics, Inc. dated June 19, 2021 (Filed With SEC on June 23, 2021)

Description of Securities of Heat Biologics, Inc (Filed With SEC on March 25, 2021)

Amendment No. 3 to the Rights Agreement dated as of March 8, 2021 to the Rights Agreement dated March 11, 2018, as amended by Amendment No. 1 thereto, dated as of March 8, 2019,... (Filed With SEC on March 12, 2021)

Amendment to Offer Letter between Heat Biologics, Inc. and William Ostrander, dated as of January 4, 2021 (Filed With SEC on January 6, 2021)

Separation Agreement dated December 31, 2020 between Heat Biologics, Inc. And Jeff Hutchins (Filed With SEC on January 6, 2021)

Form of Restricted Stock Agreement (Filed With SEC on January 6, 2021)

Employment Agreement between Heat Biologics, Inc. and Jeffrey Wolf, dated as of January 4, 2021 (Filed With SEC on January 6, 2021)

Exclusive License Agreement between the University of Miami and Zolovax, Inc. dated as of December 31, 2020 (Filed With SEC on January 6, 2021)

Amendment to License Agreement (UMSS-114A) between the University of Miami and Heat I, Inc. effective February 18, 2011 (Filed With SEC on December 10, 2020)

Amendment to License Agreement (D-107) between the University of Miami and Heat I, Inc. effective February 18, 2011 (Filed With SEC on December 10, 2020)

Amendment to License Agreement (UMSS-114) between the University of Miami and Heat Biologics, Inc. effective July 11, 2008 (Filed With SEC on December 10, 2020)

Amendment to License Agreement (UMI-176) between the University of Miami and Heat Biologics, Inc. effective December 12, 2010 (Filed With SEC on December 10, 2020)

Amendment No. 1, dated April 23, 2020, to the At Market Issuance Sales Agreement, by and between Heat Biologics, Inc. and B. Riley FBR, Inc. dated April 3, 2019 (Filed With SEC on April 23, 2020)

Attachment F to CPRIT Contract (Filed With SEC on April 10, 2020)

Description of Securities of Heat Biologics, Inc (Filed With SEC on March 30, 2020)

Form of Exchange Agreement (Filed With SEC on March 3, 2020)

Form of Investor Agreement (Filed With SEC on January 21, 2020)

Form of Warrant (Filed With SEC on January 21, 2020)

Underwriting Agreement, dated January 16, 2020, between Heat Biologics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on January 21, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on January 13, 2020)

Amendment to Offer Letter between Heat Biologics, Inc. and William Ostrander, effective as of January 1, 2020 (Filed With SEC on January 3, 2020)

Amendment to Employment Agreement between Heat Biologics, Inc. and Jeffrey Wolf, effective as of January 1, 2020 (Filed With SEC on January 3, 2020)

Form of Heat Biologics, Inc. Restricted Stock Agreement (Filed With SEC on January 3, 2020)

Amendment to Employment Agreement between Heat Biologics, Inc. and Jeffrey T. Hutchins, effective as of January 1, 2020 (Filed With SEC on January 3, 2020)

Attachment F to CPRIT Contract (Filed With SEC on November 22, 2019)

Investor Agreement (Filed With SEC on November 5, 2019)

Form of Common Stock Purchase Warrant (Filed With SEC on October 25, 2019)

Form of Underwriting Agreement (Filed With SEC on October 25, 2019)

Offer Letter by and between Heat Biologics, Inc. and William L. Ostrander, dated September 23, 2019 (Filed With SEC on September 24, 2019)

Agreement by and between Heat Biologics, Inc. and Robert J. Jakobs, dated September 20, 2019 (Filed With SEC on September 24, 2019)

Lease between Durham KTP Tech 7, LLC and Heat Biologics, Inc. dated April 17, 2019 (Filed With SEC on April 18, 2019)

Attachment F to CPRIT Contract (Filed With SEC on April 18, 2019)

At Market Issuance Sales Agreement, dated April 3, 2019, by and between Heat Biologics, Inc. and B. Riley FBR, Inc (Filed With SEC on April 4, 2019)

Amendment No. 1 to the Rights Agreement dated as of March 8, 2019 to the Rights Agreement dated March 11, 2018 by and between Heat Biologics, Inc. and Continental Stock Transfer &... (Filed With SEC on March 12, 2019)

Offer Letter by and between Heat Biologics, Inc. and Robert J. Jakobs, dated March 7, 2019 (Filed With SEC on March 12, 2019)

Agreement by and between Heat Biologics, Inc. and Ann A. Rosar, dated March 7, 2019 (Filed With SEC on March 12, 2019)

Heat Biologics, Inc. Form of Restricted Stock Agreement (Filed With SEC on January 3, 2019)

Amendment to Employment Agreement between Heat Biologics, Inc. and Jeffrey T. Hutchins, effective as of January 1, 2019 (Filed With SEC on January 3, 2019)

HEAT BIOLOGICS, INC. (63)